Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A neoplasm with neuroendocrine differentiation that arises from the stomach. It includes well differentiated neuroendocrine tumors (low and intermediate grade) and poorly differentiated neuroendocrine carcinomas (high grade).
Biomarker and diagnostic research for gastric neuroendocrine neoplasm has been reported in the published literature.
Estimated prevalence: 1-9 in 100,000 (Uncommon).
No clinical trials have been registered for gastric neuroendocrine neoplasm.
203 publications have been identified in PubMed for gastric neuroendocrine neoplasm. Research spans Review / Meta-Analysis (23%), Basic Science / Preclinical (19%), and Clinical Trial Publication (18%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 46 | 23% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 6:57 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research
39 |
19% |
Clinical study results | 36 | 18% |
Disease patterns and progression | 36 | 18% |
Testing and diagnosis research | 31 | 15% |
Patient case studies | 8 | 4% |
New treatment approaches | 7 | 3% |
Buchner AM (2026). [PMID: 41711625](https://pubmed.ncbi.nlm.nih.gov/41711625/). *Clin Gastroenterol Hepatol*. [Review / Meta-Analysis]
Baum RP (2026). [PMID: 41204752](https://pubmed.ncbi.nlm.nih.gov/41204752/). *Journal of neuroendocrinology*. [Gene Therapy / Novel Therapeutics]
Liang X (2026). [PMID: 41352470](https://pubmed.ncbi.nlm.nih.gov/41352470/). *J Ethnopharmacol*. [Diagnostic / Biomarker]
Lee CL (2026). [PMID: 41698886](https://pubmed.ncbi.nlm.nih.gov/41698886/). *Nat Commun*. [Gene Therapy / Novel Therapeutics]
Zhang Y (2026). [PMID: 41780615](https://pubmed.ncbi.nlm.nih.gov/41780615/). *J Ethnopharmacol*. [Basic Science / Preclinical]
Yuan G (2026). [PMID: 41330310](https://pubmed.ncbi.nlm.nih.gov/41330310/). *Eur J Radiol*. [Clinical Trial Publication]
Boschetti M (2026). [PMID: 41407024](https://pubmed.ncbi.nlm.nih.gov/41407024/). *Semin Cancer Biol*. [Review / Meta-Analysis]
Vijayvergia N (2026). [PMID: 41236448](https://pubmed.ncbi.nlm.nih.gov/41236448/). *Gastroenterology*. [Basic Science / Preclinical]
Lahner E (2026). [PMID: 41198445](https://pubmed.ncbi.nlm.nih.gov/41198445/). *Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver*. [Review / Meta-Analysis]
Ocasio Quinones GA (2026). [PMID: 32809560](https://pubmed.ncbi.nlm.nih.gov/32809560/). *Unknown Journal*. [Basic Science / Preclinical]